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Letter by Harris et al Regarding Article,
“Outcomes of Patients With Acute Type A Aortic
Intramural Hematoma”
To the Editor:
We read with interest the report by Song et al1 outlining the
management of ascending aortic intramural hematoma (IMH) at the
Asan Medical Center in Seoul, South Korea. This series, the largest
of this life-threatening condition, demonstrated that at that institu-
tion, 84% of patients (n85) could be treated with initial medical
therapy, resulting in a mortality rate of 7.1%. These results are
impressive but are observational rather than a randomized compar-
ison of medical and surgical therapy. “Unstable” patients were
selected to undergo emergent surgery, and the remainder of “stable”
patients were treated medically. The medically treated patients
underwent weekly imaging studies and a prolonged hospitalization
(the length of which is not specified), yet 29% required surgery at a
median of 27 days. Of note, 4 patients who were classified as stable
died suddenly between 5 and 36 months after presentation.
There has long been concern about the increased mortality in type
A IMH in North American and European populations.2 In the
International Registry of Aortic Dissection population of mainly
North American/European centers, the mortality rate for type A IMH
was 39%.3 Our pooled analysis suggests that medical therapy for
ascending IMH is associated with a dramatically higher mortality in
North America/Europe compared with Asia (33.3% versus 7.8%;
P0.0001).2 In the most recent North American series, 80% of type
A IMHs were treated with initial medical management and eventual
repair. Progression to aortic dissection requiring surgical repair
occurred in 33% of patients, with the most significant risk after the
first week.4 Conversion from IMH to aortic dissection is consistently
seen in 1 of 4 patients presenting with IMH at North American/
European sites.2 There is currently no explanation for the interna-
tional differences in the incidence and mortality rates for IMH, but
they may be related to differences in pathogenicity or in the
sensitivity of detection.2 As suggested in the thoughtful editorial5
and shown in the IRAD series,3 there are likely differences in
recognition, with Asian series including more subtle cases. Regard-
less, extrapolation of the results of Song et al to the North
American/European population should be made with caution.
The central question is how to manage a patient with acute
ascending IMH in North America/Europe. Although it is true that
many patients may survive with initial medical therapy and have
resorption of the IMH,5 the disease course with medical therapy for
ascending IMH is unpredictable and frequently associated with
cardiac tamponade, acute aortic dissection, emergency surgery, and
sudden death.1–4 Although there may be predictors as to who may
respond to medical therapy such as initial aortic diameter and
hematoma thickness, prospective studies are needed for verification.
Therefore, although we agree that certain high-risk patients could be
offered initial medical therapy, this approach should be tempered by
the potential for sudden, disastrous demise. Surgical therapy for
acute ascending IMH should still be considered the treatment of
choice for most patients in North America/Europe until results from
further prospective studies suggest otherwise.
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